Department of Pathology Microbiology and Immunology

November 4, 2024

James Crowe Jr. honored for his innovative research on human antibodies

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.

By Bill Snyder
September 20, 2024

VUMC method tracks down rare, broadly reacting antibodies: study

The discovery, reported in the journal PLOS Pathogens, could help open the door to the development of effective vaccines and antibody therapies with an “exceptional breadth of pathogen coverage.”

By Bill Snyder
September 20, 2024

Fever drives enhanced activity, mitochondrial damage in immune cells

The mechanistic understanding of how cells respond to heat could explain how chronic inflammation contributes to the development of cancer.

By Leigh MacMillan
September 4, 2024

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

By Leigh MacMillan
August 16, 2024

Rare diseases point to connections between metabolism and immunity

Science Immunology study suggests a new class of inborn errors of immunometabolism and could improve care for patients with these complex diseases.

By Leigh MacMillan
July 19, 2024

Vanderbilt, Meharry graduate students among the 2024 HHMI Gilliam Fellows

They are the only two from Tennessee named this year for the program, which provides support for each student’s dissertation research for up to three years.

By Bill Snyder
June 21, 2024

Salmonella bacteria ‘steal’ nutrients from gut’s resident microbes

The discovery could point to novel strategies for treating food poisoning and other types of gastroenteritis.
By Leigh MacMillan
June 12, 2024

Obesity-cancer connection discovery suggests strategies for improving immunotherapy 

The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy.
By Leigh MacMillan
May 28, 2024

Jennifer Gordetsky honored for her history of urology research

Jennifer Gordetsky, MD, believes the most important part of medical history is making sure our mistakes are not forgotten
By Bill Snyder
April 22, 2024

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.
By Bill Snyder
April 15, 2024

Mariana Byndloss receives FASEB Excellence in Science Award

The annual awards highlight outstanding achievements by women in the biological sciences.
By Leigh MacMillan
April 2, 2024

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.
By Bill Snyder
March 29, 2024

VUMC’s John Koethe named director of the Tennessee Center for AIDS Research

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.
By Bill Snyder
1 2 3 4 … 30